AllyGPO Wins Silver Stevie Award for AllyIQ Platform

Sep 29, 2026
AllyGPO received a Silver Stevie Award for AllyIQ, its AI enabled platform for drug contracting, inventory management and predictive analytics.

AllyGPO announced in a press release that it won a Silver Stevie Award for Technical Innovation of the Year in Healthcare Technology in the Pharmaceuticals and Biotechnology category. The 2026 award recognizes AllyIQ, its AI enabled practice intelligence platform.

AllyIQ supports independent community oncology and retina practices and manages data for more than 4 million patients. It combines computer vision, machine learning and agentic AI to automate drug purchasing and inventory management, manage contracts and rebates, and identify operational issues.

AllyGPO reports that the platform reduces drug ordering time by 75%, provides 99% drug audit accuracy, speeds rebate payments by 35 days and reduces inventory days on hand by 10%.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.